Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era

Transplantation of hearts from hepatitis C virus (HCV)-positive donors has increased substantially in recent years following development of highly effective direct-acting antiviral therapies for treatment and cure of HCV. Although historical data from the pre–direct-acting antiviral era demonstrated...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of cardiac failure 2024-05, Vol.30 (5), p.694-700
Hauptverfasser:	AMANCHERLA, KAUSHIK, FEURER, IRENE D., REGA, SCOTT A., CLUCKEY, ANDREW, SALIH, MOHAMED, DAVIS, JONATHAN, PEDROTTY, DAWN, OOI, HENRY, RALI, ANIKET S., SIDDIQI, HASAN K., MENACHEM, JONATHAN, BRINKLEY, DOUGLAS M., PUNNOOSE, LYNN, SACKS, SUZANNE B., ZALAWADIYA, SANDIP K., WIGGER, MARK, BALSARA, KEKI, TRAHANAS, JOHN, MCMASTER, WILLIAM G., HOFFMAN, JORDAN, PASRIJA, CHETAN, LINDENFELD, JOANN, SHAH, ASHISH S., SCHLENDORF, KELLY H.
Format:	Artikel
Sprache:	eng
Schlagworte:	cardiac allograft vasculopathy CAV donor HCV Heart transplant
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!